MetLife, Inc.
MET
$81.07
-$0.34-0.42%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 76.74B | 75.97B | 71.43B | 71.04B | 71.23B |
| Total Other Revenue | 848.00M | 1.11B | 499.00M | 1.97B | 2.27B |
| Total Revenue | 77.58B | 77.08B | 71.93B | 73.01B | 73.49B |
| Cost of Revenue | 59.15B | 59.07B | 54.48B | 54.23B | 54.53B |
| Gross Profit | 18.43B | 18.01B | 17.45B | 18.78B | 18.96B |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 13.24B | 12.80B | 12.48B | 12.25B | 12.12B |
| Total Operating Expenses | 72.39B | 71.87B | 66.96B | 66.48B | 66.65B |
| Operating Income | 5.19B | 5.21B | 4.97B | 6.54B | 6.84B |
| Income Before Tax | 4.81B | 4.66B | 4.93B | 5.71B | 5.93B |
| Income Tax Expenses | 1.20B | 1.26B | 1.06B | 1.41B | 1.41B |
| Earnings from Continuing Operations | 3.62K | 3.40K | 3.86K | 4.30K | 4.52K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4.00M | -24.00M | -21.00M | -14.00M | -15.00M |
| Net Income | 3.62B | 3.38B | 3.84B | 4.29B | 4.50B |
| EBIT | 5.19B | 5.21B | 4.97B | 6.54B | 6.84B |
| EBITDA | 5.94B | 5.96B | 5.68B | 7.25B | 7.56B |
| EPS Basic | 5.20 | 4.74 | 5.35 | 5.94 | 6.18 |
| Normalized Basic EPS | 4.56 | 4.32 | 4.51 | 5.16 | 5.30 |
| EPS Diluted | 5.17 | 4.71 | 5.32 | 5.91 | 6.14 |
| Normalized Diluted EPS | 4.54 | 4.29 | 4.48 | 5.13 | 5.27 |
| Average Basic Shares Outstanding | 2.65B | 2.68B | 2.71B | 2.75B | 2.79B |
| Average Diluted Shares Outstanding | 2.66B | 2.69B | 2.73B | 2.76B | 2.80B |
| Dividend Per Share | 2.27 | 2.25 | 2.23 | 2.20 | 2.18 |
| Payout Ratio | 46.42% | 50.40% | 44.44% | 39.96% | 38.25% |